National Trends and Outcomes in the Use of Intravesical Botulinum Toxin and Enterocystoplasty Among Patients With Myelomeningocele-Reference-Cited by-同舟云学术

National Trends and Outcomes in the Use of Intravesical Botulinum Toxin and Enterocystoplasty Among Patients With Myelomeningocele

Published:2022-08 Issue: Volume:166 Page:289-296
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Matta Rano,Horns Joshua J.,Jacobson Deborah L.,Schaeffer Anthony J.,Wallis M. Chad,Lau Glen A.

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: a systematic review;Hoen;Neurourol Urodyn,2017

2. Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: a systematic review;Hascoet;Neurourol Urodyn,2017

3. A review of botulinum toxin a for the treatment of neurogenic bladder;Cooley;PM R,2019

4. Allergan. BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age. clinicaltrials.gov; 2019. Available at: https://clinicaltrials.gov/ct2/show/results/NCT01852045. Accessed April 4, 2021.

5. Single-center experience with botulinum toxin endoscopic detrusor injection for the treatment of congenital neuropathic bladder in children: Effect of dose adjustment, multiple injections, and avoidance of reconstructive procedures;Figueroa;J Pediatr Urol,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 Canadian Urological Association/ Pediatric Urologists of Canada guideline: Pediatric patients with neurogenic lower urinary tract dysfunction;Canadian Urological Association Journal;2023-10-05